Yahoo

3 UK Exporter Stocks That Could Hold Up Better If Politics Shifts

UK politics is being ripped up again, with talk of a more left leaning Labour government under Andy Burnham, possible electoral reform and even Brexit being revisited. That mix is shaking assumptions about regulation, tax and the pound, which can punish some domestically focused groups while leaving certain global exporters relatively better placed. This article walks through three UK large cap stocks exposed to this news and explains how their international reach could matter for your portfolio decisions now.

The stocks covered next are just a starter set for this idea, and the full screen surfaced 9 more UK large cap exporters and multinationals with equally compelling stories that are not covered here. If you want to identify your own favourites, head straight to the UK Large-Cap Exporters and Multinationals screener to filter and analyze the wider group.

RS Group (LSE:RS1)

Overview:RS Group is a global distributor of industrial maintenance and automation products and services, giving UK investors meaningful exposure to overseas demand.

Operations:RS Group generated about £2.47b from other product and service solutions and £414.9 million from RS PRO, spread across the UK, US and wider international markets.

Market Cap:£3.59b

RS Group matters in this exporters screen because much of its income comes from outside the UK, which can blunt purely domestic policy shocks while still linking your returns to global industrial spending cycles.

"Global acceleration in industrial automation and digital transformation is likely to drive a multi-year surge in demand for RS Group's broad and technical product range, positioning the company to outpace peers and deliver structurally higher top-line revenue growth as cyclical headwinds abate."

What ultimately happens to RS Group's earnings will lean heavily on one pressure point that could reshape how customers source critical components.

That sourcing shift is the real hinge for RS Group, and the full narrative for RS Group shows how automation demand, pricing power and customer stickiness could all be pulling in different directions.

LSE:RS1 Earnings & Revenue History as at Oct 2026
LSE:RS1 Earnings & Revenue History as at Oct 2026

Bunzl (LSE:BNZL)

Overview:Bunzl is a London based distributor that supplies everyday packaging, cleaning, safety and healthcare consumables to businesses worldwide.

Operations:Bunzl recorded about £12.02b of revenue from Packaging & Containers, with roughly £6.28b in North America and £2.53b in Continental Europe.

Market Cap:£8.39b

Bunzl fits this exporters screen as a large UK listed distributor whose earnings lean heavily on North American and European demand rather than the UK cycle, which can matter if a more interventionist government or a shift on Brexit changes the local playing field.

"The turnaround of the North America Distribution business, which suffered from over-centralization and execution missteps but is now regaining local autonomy, improving service and inventory levels, and re-energizing sales teams, is intended to support a recovery in revenue growth and operating margin beginning in H2 2025 and continuing through 2026, though current results do not yet fully reflect these changes."

What happens to Bunzl's margins from here will hinge on how one quiet pressure on its international contract mix ultimately resolves.

That quiet contract pressure is exactly where the full narrative for Bunzl shows how Bunzl could turn mix shifts, pricing and volumes into a stronger long term earnings story.

LSE:BNZL Revenue & Expenses Breakdown as at Oct 2026
LSE:BNZL Revenue & Expenses Breakdown as at Oct 2026

Diploma (LSE:DPLM)

Overview:Diploma supplies specialised controls, seals and life sciences equipment across Europe, North America and other regions, giving UK investors broad international exposure.

Operations:Diploma generated £940.4 million from Controls, £454.2 million from Seals and £252.5 million from Life Sciences, with most revenue earned outside the UK.

Market Cap:£10.36b

Diploma matters in this exporters screen because the bulk of its activity is tied to overseas industrial and healthcare demand rather than the UK policy cycle. Investors are really judging how a technical distributor can keep compounding abroad while Westminster rewrites the domestic rulebook.

"Continued integration and cross-selling potential from recent acquisitions (Haagensen and Alfa Laboratories) provide increased exposure to high-growth life sciences and sealing solutions markets, positioning Diploma to capture revenue synergies and drive future organic growth, supporting both revenue and margin expansion."

What happens to Diploma's premium margins from here may depend on how one quiet shift in its global pricing power ultimately plays out.

That pricing shift is exactly where the full narrative for Diploma shows whether Diploma's premium margins are quietly stalling or accelerating under the surface.

LSE:DPLM Revenue & Expenses Breakdown as at Oct 2026
LSE:DPLM Revenue & Expenses Breakdown as at Oct 2026

Seeking Fresh Alternatives Beyond These Three

Some of the most interesting ideas often move first. Breakout momentum, flying under radar for now, can get caught quickly once the crowd arrives, so act now.

  • Spot early turnarounds in quality operators before momentum traders arrive by scanning the 8 high quality undervalued stocks while the pricing disconnect still matters for patient buyers.

  • Track accelerating demand in next wave automation and chip suppliers using the curated 90 AI infrastructure stocks so you see potential beneficiaries before enthusiasm peaks.

  • Target resilient operators with room to compound through different cycles by working through the hand picked 4 resilient stocks with low risk scores while they remain under the radar for now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: